Due: November 1, 2024 This solicitation is issued by the CWMD Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for the 2024 “CWMD Commercialization Grant” mechanism. Responding to this Read More
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous Read More
Anticipated Release Date: Q3FY25 SIS will provide the capability to temporarily isolate or quarantine personnel to prevent the spread of a biological threat and safely evacuate patients for transfer off the ship. Capability will contain Read More
Anticipated Release Date: Q3FY26 ASPIRE will provide respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear threats that allows near normal operations by minimizing or eliminating physical and psychological burden and increasing Warfighter lethality. Read More
Due: March 13, 2025 The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Read More
April 25, 2025 This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Read More
Due: March 17, 2025 The Division of Mathematical Sciences (DMS) in the Directorate for Mathematical and Physical Sciences (MPS) at the National Science Foundation (NSF) and the Air Force Office of Scientific Research (AFOSR) plan Read More
Due: January 5, 2025 This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR) projects to develop novel tools and devices to improve handling of laboratory animals, Read More
Due: January 7, 2025 The purpose of this Funding Opportunity Announcement (FOA) is to support basic research that elucidates mechanisms by which the human microbiome inhibit or enhance anti-tumor immune responses, and to identify potential Read More
Due: December 15, 2024 The U.S. Fish and Wildlife Service (Service) makes funding available for research and conservation action to support the management of white-nose syndrome (WNS) and susceptible bat species. The Service leads the Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.